119 related articles for article (PubMed ID: 6761633)
1. The pathobiology of lymphocyte transformation.
Taylor CR
Pathobiol Annu; 1982; 12():65-84. PubMed ID: 6761633
[No Abstract] [Full Text] [Related]
2. [A lymphoproliferative disorder of T-cell origin with appearances of chronic lymphatic leukemia].
Thoden van Velzen AH; Bom-van Noorloos AA; Feltkamp-Vroom TM; von dem Borne AE; Melief CJ; Silberbusch J
Ned Tijdschr Geneeskd; 1979 Dec; 123(51):2172-7. PubMed ID: 317509
[No Abstract] [Full Text] [Related]
3. T-cell lymphomas and leukemias of post-thymic differentiation.
Kadin ME; Said J
Clin Lab Med; 1988 Mar; 8(1):135-50. PubMed ID: 2896086
[TBL] [Abstract][Full Text] [Related]
4. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma and acquired angioedema: a novel association?
Rossi D; Gaidano G
Ann Ital Med Int; 2002; 17(3):143-5. PubMed ID: 12402660
[No Abstract] [Full Text] [Related]
6. [Benign and malignant lymphoproliferative processes associated with the murine islet system].
Freytag G; Kolb-Bachofen V; Kiesel U; Kolb H
Verh Dtsch Ges Pathol; 1981; 65():255-61. PubMed ID: 6750953
[No Abstract] [Full Text] [Related]
7. [Spectrum of lymphoproliferative diseases].
Franssila K
Duodecim; 1989; 105(11):1016-39. PubMed ID: 2666087
[No Abstract] [Full Text] [Related]
8. [Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)].
Minato K; Shimoyama M
Rinsho Byori; 1978; 26(3):194-200. PubMed ID: 306459
[No Abstract] [Full Text] [Related]
9. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
Pintado Cros T
Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
[No Abstract] [Full Text] [Related]
10. [Immunologic cell markers in lymphoproliferative diseases].
Samoĭlova RS
Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
[No Abstract] [Full Text] [Related]
11. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases].
Pecze K; Dalmi L; Rák K
Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087
[No Abstract] [Full Text] [Related]
12. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
13. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lymphocyte subsets of X-linked lymphoproliferative syndrome.
Seeley J; Sakamoto K; Ip SH; Hansen PW; Purtilo DT
J Immunol; 1981 Dec; 127(6):2618-20. PubMed ID: 6271875
[No Abstract] [Full Text] [Related]
15. Natural killer cell neoplasms.
Chan JK
Anat Pathol; 1998; 3():77-145. PubMed ID: 10389582
[No Abstract] [Full Text] [Related]
16. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
17. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
Khatri VP; Baiocchi RA; Peng R; Oberkircher AR; Dolce JM; Ward PM; Herzig GP; Caligiuri MA
J Immunol; 1999 Jul; 163(1):500-6. PubMed ID: 10384154
[TBL] [Abstract][Full Text] [Related]
18. [Typification of the immunoproliferative syndromes].
Leoni P
Minerva Med; 1982 Apr; 73(15):911-4. PubMed ID: 6281685
[No Abstract] [Full Text] [Related]
19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
20. [Clinical lymphocyte markers: interpretation and indications].
Preud'homme JL
Presse Med; 1985 Mar; 14(12):669-71. PubMed ID: 3157960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
